| Active ingredient (INN) | Deferasirox |
|---|---|
| Brand names | Deferasirox Stada, EFERAS deferasirox |
| ATC level 5 | V03AC03 |
| ATC level 4 | V03AC |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Novartis Pharmaceuticals Australia Pty Ltd, Alembic Pharmaceuticals Australia Pty Ltd, Juno Pharmaceuticals Pty Ltd, Pharmacor Pty Ltd +2 more |
| Registrations on file | 27 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| JADENU deferasirox | 360 mg | — | 🇦🇺 AU | Novartis Pharmaceuticals Australia Pty Ltd | Active |
| JADENU deferasirox | 90 mg | — | 🇦🇺 AU | Novartis Pharmaceuticals Australia Pty Ltd | Active |
| Alembic | 360 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |
| Alembic | 180 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |
| Juno | 250 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| Deferasirox Juno | 125 mg | — | 🇦🇺 AU | Juno Pharmaceuticals Pty Ltd | Active |
| CHEALAC deferasirox | 180 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |
| Pharmacor | 500 mg | — | 🇦🇺 AU | Pharmacor Pty Ltd | Active |
| Pharmacor | 250 mg | — | 🇦🇺 AU | Pharmacor Pty Ltd | Active |
| Akm | 250 mg | — | 🇦🇺 AU | Pharmacor Pty Ltd | Active |
| Akm | 500 mg | — | 🇦🇺 AU | Pharmacor Pty Ltd | Active |
| CHEALAC deferasirox | 90 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |
| Alembic | 90 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |
| CHEALAC deferasirox | 360 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |
| Teva | 360 mg | — | 🇦🇺 AU | Teva Pharma Australia Pty Ltd | Active |